Lineage Cell Therapeutics Q4 EPS $0.00 Beats $(0.05) Estimate, Sales $6.600M Beat $2.577M Estimate
Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.05) by 108.51 percent. This is a 120 percent increase over losses of $(0.02) per share
